Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This is according to the large randomized controlled START trial.
The opioid epidemic is likely fueling increased rates of deceased organ donors categorized as posing a high risk of passing on such viruses.
Researchers analyzed 10 biomarkers associated with biological aging among a group of HIV-positive and -negative Europeans.
In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
Those who begin antiretrovirals with a higher CD4 count and CD4 to CD8 ratio are more likely to experience immune recovery.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
In a recent trial, Gilead’s regimen was highly successful in a group that included those with and without HIV coinfection.
One researcher argues that the pharmaceutical industry ought to pay greater heed to such risks during drug development.
Born with hemophilia. Diagnosed with hepatitis B at age 6. HIV at age 11. Hep C at age 18. I am the embodiment of a pre-existing condition.
Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.